Projects

International

• Nanobiotechnologies for Innovative Therapeutic Approaches for Cancer
  Program: Horizon Europe
  Duration: 1. 11. 2023 – 31. 10. 2028

• European Network for Skin Engineering and Modeling
  Program: COST
  Duration: 15. 9. 2022 – 14. 9. 2026

• TEmperature-responsive Nanogels for TArgeted delivery of miCroRNAs in wound heaLing and tissue rEgeneration applicationS
  Program: ERANET
  Duration: 1. 2. 2020 – 31. 1. 2024

• Cancer Nanomedicine - from the bench to the bedside
  Program: COST
  Duration: 28. 9. 2018 – 27. 3. 2023

• In vitro 3-D total cell guidance and fitness
  Program: COST
  Duration: 16. 3. 2017 – 15. 9. 2021

National

• Effect of Dietary Supplements on Follicular Fluid in Female Infertility: Mitigating Oxidative Stress
  Program: VEGA
  Duration: 1. 1. 2024 – 31. 12. 2027

• Application of natural plants oils and extracts for foodpackaging
  Program: SRDA
  Duration: 1. 7. 2024 – 30. 6. 2027

• Novel renal antisense therapy platform for CKD
  Program: SRDA
  Duration: 1. 8. 2021 – 30. 6. 2025

• Use of microfluidic systems for risk assessment of xenobiotics
  Program: VEGA
  Duration: 1. 1. 2021 – 31. 12. 2024

• Newly syntethized thymol derivatives: relationship between structure and biological activity in colorectal in vitro model.
  Program: VEGA
  Duration: 1. 1. 2020 – 31. 12. 2023

• Glycoprofiling of proteins present in serum and exosomes for early prostate cancer diagnostics
  Program: Other projects
  Duration: 1. 12. 2019 – 30. 12. 2022

• Gold nanoparticles: impact of physicochemical properties on distribution, accumulation, and biological response in vivo (BIONANOGOLD)
  Program: SRDA
  Duration: 1. 7. 2017 – 30. 6. 2021

• Induction of apoptosis by betulinic acid coupled to magnetite nanoparticles in human colorectal cell lines
  Program: VEGA
  Duration: 1. 1. 2017 – 31. 12. 2020

• Antioxidative, anticarcinogen and photoprotective effects of the essential oil from lavender in vitro.
  Program: VEGA
  Duration: 1. 1. 2016 – 31. 12. 2019